The Story of Maryland’s Cell and Gene Therapy Cluster is Shared Loud and Clear at Inaugural Bio Innovation Conference

Published on :

The Story of Maryland’s Cell and Gene Therapy Cluster is Shared Loud and Clear at Inaugural Bio Innovation Conference October 8, 2019 On Monday morning in Bethesda, Maryland hundreds of industry leaders emerged from a large ballroom at the inaugural Bio Innovation Conference, hosted by Maryland Life Sciences, a division of the Maryland Tech Council. [….]

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform

Dhana Chinnasamy, PhD
Published on :

MaxCyte Adds Vice President, Non-Clinical and Translational Studies, to Support Advancement of Programs from Its CARMA™ Platform Dhana Chinnasamy, PhD, will oversee non-clinical and translational activities for MaxCyte’s autologous cell therapy platform for targeted cell-based immune therapies GAITHERSBURG, Md., July 23, 2019 /PRNewswire/ — MaxCyte, the global clinical-stage cell-based therapies and life sciences company, announced today that it [….]

Cell Therapy to Replace All Modern Medicine?

Published on :

Cell Therapy to Replace All Modern Medicine? In order: Phil Vanek, PhD (GE Healthcare); Claudia Zylberberg, PhD (Akron Biotechnology); Joshua Hare, MD (Longeveron); Doug Doerfler (Maxcyte) participate in the “Realizing the Potential of Stem Cell Therapies” panel at the TEDCO Entrepeneur Expo November 9, 2018 The TEDCO Stem Cell Symposium included several speakers and panels [….]